+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Peripherally Inserted Central Catheter Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 189 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016121
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global Peripherally Inserted Central Catheter market is evolving as healthcare leaders prioritize efficiency, innovation, and new approaches to clinical care. Senior decision-makers in the sector face opportunities to drive better outcomes and optimize procurement strategies, responding to the ongoing demands of modern healthcare delivery.

Market Snapshot: Global Peripherally Inserted Central Catheter Market

The global Peripherally Inserted Central Catheter (PICC) market demonstrated consistent growth in 2024, reaching a valuation of USD 1.03 billion, with projections indicating a rise to USD 1.07 billion in 2025 and an estimated compound annual growth rate (CAGR) of 4.00%. By 2032, analysts expect the market to achieve a value of USD 1.41 billion. This upward trend is attributed to ongoing advances in material science, increased adoption of PICCs in outpatient and home settings, and strengthened supply chain strategies. Demand for long-term vascular access solutions is rising, shaping opportunities for providers across hospitals, ambulatory centers, and home health agencies as clinical practices and procurement priorities evolve.

Scope & Segmentation of the Peripherally Inserted Central Catheter Market

This report delivers segmentation that supports executive decision-making in procurement, clinical implementation, and strategic planning related to the Peripherally Inserted Central Catheter market. The analysis examines factors driving engagement across both established and emerging healthcare landscapes, helping organizations align with current and future needs.

  • Product Types: Encompasses open ended coaxial catheters, power injectable catheters, and valved coaxial catheters, all designed for flexibility with single-lumen and multi-lumen configurations. Diverse product features enable tailored use across varying procedural demands.
  • Material Types: Examines polyurethane catheters, which now include antimicrobial-coated versions, as well as silicone catheters equipped with antithrombogenic coatings. These enhancements drive compatibility and play a critical role in infection prevention.
  • End User Segments: Highlights the operational needs and workflow patterns typical of ambulatory surgery centers, dialysis centers, home care providers, and hospitals serving a wide spectrum of patient populations.
  • Clinical Indications: Assesses applications in both acute and chronic care, from antibiotic delivery and chemotherapy (for both hematologic and solid tumors) to intravenous therapies, hydration, pain management, and parenteral nutrition.
  • Distribution Channels: Explores hospital and retail pharmacy models alongside online procurement platforms, reflecting shifts in inventory management practices and the rise of digital ordering systems among healthcare providers.
  • Regional Coverage: Provides market insights and segmentation for key global regions such as the Americas, EMEA, and Asia-Pacific, with in-depth analysis dedicated to the United States, China, India, Japan, Australia, and South Korea. These regions are shaping differentiated market dynamics and procurement approaches.
  • Technology Trends: Evaluates uptake of antimicrobial and antithrombogenic coatings, increased adoption of digital workflows, and the integration of power-injectable and multi-lumen catheter technologies. These advances facilitate safety, patient outcomes, and workflow improvements.

Key Takeaways for Senior Decision-Makers

  • PICCs are central to critical care pathways, supporting oncology treatments, infection control, and nutritional or infusion therapy as patient-centric and value-based models become more prominent.
  • Adoption of biocompatible catheter materials and digital monitoring platforms helps minimize infection rates, optimize procedural flows, and deliver durable solutions adaptable to complex patient needs.
  • Simulation-based procurement strategies are enhancing staff training and advancing patient safety metrics, supporting continuous supply chain performance improvements.
  • Device manufacturers, healthcare providers, and regulatory stakeholders are cultivating partnerships to expand access and facilitate rapid adoption of advanced catheter technologies in varied care contexts.
  • Growth in direct purchasing methods and the expansion of online distribution channels contribute to agile inventory management, ensuring facilities can respond quickly to changing clinical demand.
  • Diverse product portfolios enable precise matching of device specifications to clinical needs, refining care planning and reducing unnecessary procedures.

Tariff Impact on Supply Chain Dynamics

Recent tariffs on imported PICC components within the United States have heightened cost pressures across the supply chain. In response, domestic suppliers are scaling up polymer manufacturing capacity while original equipment manufacturers adjust sourcing and supplier relationships. These measures serve to strengthen supply quality, sustain workflow, and ensure organizations maintain standards of patient care despite evolving regulatory requirements.

Methodology & Data Sources

The market research draws from regulatory filings, clinical practice guidelines, and supplier documentation, combined with interviews involving clinicians, procurement specialists, and material science experts. Validation was conducted through surveys of manufacturers and distributors, supporting the accuracy and relevance of the findings.

Why This Report Matters

  • Equips executive teams with a complete market review, enabling prioritization of high-value segments and informed investment in technology-driven innovation.
  • Delivers benchmarking tailored to research, procurement, and commercialization strategies, supporting transformation efforts in healthcare supply chains.
  • Provides the strategic foresight to address supply chain and technology integration challenges, helping organizations build resilience and enhance operational continuity.

Conclusion

As clinical and technological advancements reshape the Peripherally Inserted Central Catheter market, organizations focused on agility and digital integration are better positioned to deliver effective, resilient healthcare solutions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising adoption of antimicrobial and antithrombogenic PICC coatings to minimize infection and thrombosis
5.2. Integration of PICCs with smart infusion pumps and connected software for real time therapy monitoring
5.3. Growing demand for power injectable PICCs enabling safe high pressure contrast media administration
5.4. Expansion of home infusion therapy driving need for remote PICC monitoring and telehealth management
5.5. Regulatory emphasis on standardized clinician credentialing and ultrasound guided PICC insertion
5.6. Increasing use of ECG based tip confirmation technology to enhance placement accuracy and safety
5.7. Emergence of 3D printed and customizable PICC devices tailored to patient vascular anatomy requirements
5.8. Surge in PICC utilization in oncology and long term antibiotic treatment across aging populations
5.9. Development of biodegradable antimicrobial coatings to reduce long term catheter related complications
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Peripherally Inserted Central Catheter Market, by Product Type
8.1. Open Ended Coaxial
8.1.1. Multi Lumen
8.1.2. Single Lumen
8.2. Power Injectable
8.2.1. Multi Lumen
8.2.2. Single Lumen
8.3. Valved Coaxial
8.3.1. Multi Lumen
8.3.2. Single Lumen
9. Peripherally Inserted Central Catheter Market, by Material
9.1. Polyurethane
9.1.1. Antimicrobial Coated
9.1.2. Standard Polyurethane
9.2. Silicone
9.2.1. Antithrombogenic Coated
9.2.2. Standard Silicone
10. Peripherally Inserted Central Catheter Market, by End User
10.1. Ambulatory Surgery Centers
10.1.1. Hospital Affiliated Centers
10.1.2. Independent Centers
10.2. Dialysis Centers
10.2.1. Hospital Based
10.2.2. Standalone
10.3. Home Care Settings
10.3.1. Home Infusion Services
10.3.2. Skilled Nursing Facilities
10.4. Hospitals
10.4.1. Community Hospitals
10.4.2. Specialty Hospitals
11. Peripherally Inserted Central Catheter Market, by Indication
11.1. Antibiotic Therapy
11.1.1. Long Term Therapy
11.1.2. Short Term Therapy
11.2. Chemotherapy
11.2.1. Hematological Therapy
11.2.2. Solid Tumor Therapy
11.3. Infusion Therapy
11.3.1. Critical Care Infusion
11.3.2. Hydration Therapy
11.3.3. Pain Management Infusion
11.4. Parenteral Nutrition
11.4.1. Partial Parenteral Nutrition
11.4.2. Total Parenteral Nutrition
12. Peripherally Inserted Central Catheter Market, by Distribution Channel
12.1. Hospital Pharmacies
12.1.1. External Pharmacies
12.1.2. In House Pharmacies
12.2. Online Sales
12.2.1. Direct Manufacturer
12.2.2. Distributor Platforms
12.3. Retail Pharmacies
12.3.1. Chain Pharmacies
12.3.2. Independent Pharmacies
13. Peripherally Inserted Central Catheter Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Peripherally Inserted Central Catheter Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Peripherally Inserted Central Catheter Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Becton Dickinson and Company
16.3.2. B. Braun Melsungen AG
16.3.3. Teleflex Incorporated
16.3.4. AngioDynamics, Inc.
16.3.5. ICU Medical, Inc.
16.3.6. Medtronic plc
16.3.7. Cook Medical LLC
16.3.8. Merit Medical Systems, Inc.
16.3.9. Smiths Group plc
16.3.10. Terumo Corporation

Companies Mentioned

The companies profiled in this Peripherally Inserted Central Catheter market report include:
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • AngioDynamics, Inc.
  • ICU Medical, Inc.
  • Medtronic plc
  • Cook Medical LLC
  • Merit Medical Systems, Inc.
  • Smiths Group plc
  • Terumo Corporation

Table Information